Peptides for gene delivery
AssigneeThe Regents of the University of Michigan
InventorsKevin Gerard Rice, Manpreet S. Wadhwa
Life of this patent
Estimating the term…
Abstract
Compositions and methods are described for nucleic acid formulation for gene delivery. A new class of low molecular weight condensing agents, namely aromatic amino acid—containing peptides, are described for use in receptor-mediated and nonreceptor-mediated gene delivery, both in vivo and in vitro.
Claims20
A method, comprising:
- a) providing:
- i) nucleic acid encoding one or more gene products, ii) a tryptophan-containing peptide of less than forty amino acids in length capable of binding to said nucleic acid, and iii) a cell having a cell membrane;
- b) binding said tryptophan-containing peptide to said nucleic acid to make a complex;
- c) introducing said complex to said cell under conditions such that said complex is delivered across said cell membrane.
The method of claim 2, wherein said peptide further comprises cysteine.
A method of delivering nucleic acid to cells, comprising:
- a) providing:
- i) a cell having a receptor, ii) a target binding moiety capable of binding to said receptor, iii) nucleic acid encoding one or more gene products, and iv) a tryptophan-substituted polylysine of less than forty amino acids in length capable of binding to said nucleic acid;
- b) conjugating said target binding moiety to said tryptophan-substituted polylysine to form a carrier;
- c) coupling said carrier with said nucleic acid to form a pharmaceutical composition;
- and
- d) introducing said pharmaceutical composition to said cell under conditions such that said nucleic acid is delivered to said cell.
A method of delivering nucleic acid to cells of an animal, comprising:
- a) providing:
- i) an animal containing cells having a receptor, ii) a target binding moiety capable of binding to said receptor, iii) nucleic acid encoding one or more gene products, and iv) a tryptophan-substituted polylysine of less than forty amino acids in length capable of binding to said nucleic acid;
- b) conjugating said target binding moiety to said tryptophan-substituted polylysine to form a carrier;
- c) coupling said carrier with said nucleic acid to form a pharmaceutical composition;
- and
- d) administering said composition to said animal under conditions such that said nucleic acid is delivered to said cells.
A tryptophan-containing peptide of less than forty amino acids in length capable of binding to nucleic acid.
Dependencies are inferred from the claim text.